Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases

Pharmacol Res. 2018 Dec:138:2-15. doi: 10.1016/j.phrs.2018.08.010. Epub 2018 Aug 23.

Abstract

Mitochondria are best known for their role in ATP generation. However, studies over the past two decades have shown that mitochondria do much more than that. Mitochondria regulate both necrotic and apoptotic cell death pathways, they store and therefore coordinate cellular Ca2+ signaling, they generate and metabolize important building blocks, by-products and signaling molecules, and they also generate and are targets of free radical species that modulate many aspects of cell physiology and pathology. Most estimates suggest that although the brain makes up only 2 percent of body weight, utilizes about 20 percent of the body's total ATP. Thus, mitochondrial dysfunction greatly impacts brain functions and is indeed associated with numerous neurodegenerative diseases. Furthermore, a number of abnormal disease-associated proteins have been shown to interact directly with mitochondria, leading to mitochondrial dysfunction and subsequent neuronal cell death. Here, we discuss the role of mitochondrial dynamics impairment in the pathological processes associated with neurodegeneration and suggest that a therapy targeting mitochondrialdysfunction holds a great promise.

Keywords: Drp1; Mitochondrial dynamics; Neurodegeneration; Neuroinflammation; P110; Protein–Protein interactions.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Energy Metabolism
  • Humans
  • Mitochondria / physiology*
  • Mitochondrial Dynamics
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / physiopathology*